User contributions

From WikiPathways

Search for contributions

 Show contributions of new accounts only
 IP Address or username: Namespace: all (Main) Talk User User talk WikiPathways WikiPathways talk Image Image talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk Thread Thread talk Summary Summary talk Pw Old Pw Old Talk Pathway Pathway Talk Wishlist Wishlist Talk Portal Portal Talk

From year (and earlier): From month (and earlier): all January February March April May June July August September October November December

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)

• 21:51, 4 March 2011 Homo sapiens:Effects of PIP2 hydrolysis‎ (Automatic update)
• 21:51, 4 March 2011 Homo sapiens:DNA Damage Reversal‎ (Automatic update)
• 21:51, 4 March 2011 Homo sapiens:DNA Damage Bypass‎ (Automatic update)
• 21:51, 4 March 2011 Homo sapiens:Dissolution of Fibrin Clot‎ (Automatic update)
• 21:51, 4 March 2011 Homo sapiens:Presynaptic depolarization and calcium channel opening‎ (Automatic update)
• 21:51, 4 March 2011 Homo sapiens:Costimulation by the CD28 family‎ (Automatic update)
• 21:50, 4 March 2011 Homo sapiens:Complement cascade‎ (Automatic update)
• 21:50, 4 March 2011 Homo sapiens:Circadian Clock‎ (Automatic update)
• 21:50, 4 March 2011 Homo sapiens:Cholesterol biosynthesis‎ (Automatic update)
• 21:50, 4 March 2011 Homo sapiens:Cell surface interactions at the vascular wall‎ (Automatic update)
• 21:50, 4 March 2011 Homo sapiens:Cell junction organization‎ (Automatic update)
• 21:50, 4 March 2011 Homo sapiens:Cell cycle checkpoints‎ (Automatic update)
• 21:50, 4 March 2011 Homo sapiens:Insulin-like Growth Factor-2 mRNA Binding Proteins binding to RNA‎ (Automatic update)
• 21:50, 4 March 2011 Homo sapiens:Bile acid and bile salt metabolism‎ (Automatic update)
• 21:49, 4 March 2011 Homo sapiens:Asparagine N-linked glycosylation‎ (Automatic update)
• 21:49, 4 March 2011 Homo sapiens:Advanced glycosylation endproduct receptor signaling‎ (Automatic update)
• 21:49, 4 March 2011 Homo sapiens:ABC-family proteins mediated transport‎ (Automatic update)
• 21:30, 4 March 2011 Homo sapiens:Kinesins‎ (Automatic update)
• 21:30, 4 March 2011 Homo sapiens:Interleukin-1 processing‎ (Automatic update)
• 21:22, 4 March 2011 Homo sapiens:Immunoregulatory interactions between lymphoid and non-lymphoid cells‎ (Automatic update)
• 12:50, 4 March 2011 Homo sapiens:Sandbox pathway test‎ (Bot edit test)
• 18:02, 2 March 2011 Saccharomyces cerevisiae:Proteasome degradation‎ (Removed redundant pathway information and comments)
• 18:00, 2 March 2011 Saccharomyces cerevisiae:Nucleotide metabolism‎ (Removed redundant pathway information and comments)
• 05:03, 2 March 2011 Sus scrofa:BMP signaling and regulation‎ (Removed redundant pathway information and comments)
• 05:03, 2 March 2011 Sus scrofa:Target of rapamycin (TOR) signaling‎ (Removed redundant pathway information and comments)
• 05:03, 2 March 2011 Sus scrofa:Catalytic cycle of mammalian FMOs‎ (Removed redundant pathway information and comments)
• 05:03, 2 March 2011 Sus scrofa:Non-homologous end joining‎ (Removed redundant pathway information and comments)
• 05:03, 2 March 2011 Sus scrofa:Polyol pathway‎ (Removed redundant pathway information and comments)
• 05:03, 2 March 2011 Sus scrofa:Homologous recombination‎ (Removed redundant pathway information and comments)
• 05:03, 2 March 2011 Sus scrofa:Ebstein-Barr virus LMP1 signaling‎ (Removed redundant pathway information and comments)
• 05:03, 2 March 2011 Sus scrofa:DNA damage response‎ (Removed redundant pathway information and comments)
• 05:03, 2 March 2011 Sus scrofa:Amino acid conjugation of benzoic acid‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Pyruvate dehydrogenase pathway‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Lipid-linked oligosaccharide biosynthesis‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Sulfur amino acid biosynthesis‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Octane oxidation‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:DNA replication‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:De novo biosynthesis of pyrimidine ribonucleotides‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Glutathione-glutaredoxin redox reaction‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Aerobic glycerol catabolism‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Sucrose biosynthesis‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Glutamate degradation VIII‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Tyrosine biosynthesis‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Arginine degradation‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:MAPK signaling pathway‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Aspartate biosynthesis‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Carbon monoxide dehydrogenase pathway‎ (Removed redundant pathway information and comments)
• 04:54, 2 March 2011 Saccharomyces cerevisiae:Trehalose anabolism‎ (Removed redundant pathway information and comments)
• 04:53, 2 March 2011 Saccharomyces cerevisiae:Heme biosynthesis‎ (Removed redundant pathway information and comments)
• 04:53, 2 March 2011 Saccharomyces cerevisiae:Leucine biosynthesis‎ (Removed redundant pathway information and comments)

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)